header logo image


Page 24«..1020..23242526..30..»

Archive for the ‘Molecular Genetics’ Category

Free "LabXchange" Science Education Accelerator Launched By Amgen Foundation And Harvard’s Faculty Of Arts And Sciences – Yahoo Finance

Wednesday, January 22nd, 2020

LabXchange by Amgen Foundation and Harvard's Faculty of Arts and Sciences Reimagines the Science Experience for Students around the Globe

Purpose-Built to Address Educational Barriers With Personalized Instruction

Virtual Lab Simulations Help Students Develop the Science Skills Needed to Solve Tomorrow's Challenges

THOUSAND OAKS, Calif. and CAMBRIDGE, Mass., Jan. 22, 2020 /PRNewswire/ --The Amgen Foundation and the Faculty of Arts and Sciences at Harvard University (Harvard FAS)today announced the global launch of LabXchange, a free online science education platform that provides users with access to personalized instruction, virtual lab experiences and networking opportunities across the global scientific community. LabXchange is purpose-built to drive more inclusion in the scientific process and spark collaboration to build creative, team-based approaches to real-world problems.

Experience the interactive Multichannel News Release here: https://www.multivu.com/players/English/8490258-amgen-foundation-harvard-labxchange/

"Too many high school and college students lack the opportunity to directly explore the scientific process where you build a hypothesis, understand a method, and determine how to apply it to an appropriate experimental problem," said Robert Lue, Ph.D., principal investigator of LabXchange and professor of the Practice of Molecular and Cellular Biology at Harvard. "For many students, science can feel like a collection of facts to memorize which is contrary to what the scientific process is it's a journey that requires bold thinking and deep imagination. With LabXchange, more students can come together and experience the joy of discovery."

Featuring virtual lab experiments developed at LabXchange along with other world-class assets created by validated partners, LabXchange brings the scientific process to life. By simulating key techniques in molecular and cellular biology, like using CRISPR to correct genetic defects, students can explore a wide range of scientific methods and build their acumen in harnessing science to solve real-life problems.

"Everyone needs science, and science needs everyone," said Robert A. Bradway, chairman and chief executive officer at Amgen. "At a time of remarkable scientific progress, we're excited by the potential of LabXchange to educate and inspire both students and lifelong learners of all ages."

LabXchange is designed to level the playing field for students and to promote science literacy for all. Key features of LabXchange include:

LabXchange builds upon other Amgen Foundation programs that support science education, such as the Amgen Biotech Experience and Amgen Scholars that are also at Harvard FAS and institutions around the world. To date, the Foundation has contributed more than $150 million to advancing science education programming globally as part of its mission to facilitate global collaboration on the United Nations Sustainable Development Goals (SDGs), notably SDG #4 on Quality Education, but also SDG #3 on Good Health and Well-Being.

For more information, please visit http://www.LabXchange.org, and engage with us via @LabXchange on Twitter using #ScienceMadePossible.

About the Amgen Foundation The Amgen Foundation seeks to advance excellence in science education to inspire the next generation of innovators, and invest in strengthening communities where Amgen staff members live and work. To date, the Foundation has donated over $300 million to local, regional, and international non-profit organizations that impact society in inspiring and innovative ways. The Amgen Foundation brings the excitement of discovery to the scientists of tomorrow through several signature programs, including Amgen Scholars and the Amgen Biotech Experience. For more information, visit AmgenInspires.com and follow us on Twitter @AmgenFoundation.

About Amgen Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.

Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980,Amgenhas grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.

Story continues

For more information, visitwww.amgen.comand follow us onTwitter @Amgen.

About the Faculty of Arts and Sciences at Harvard University The Faculty of Arts and Sciences is the largest of the seven faculties that constitute Harvard University and is the only division of the university responsible for both undergraduate and graduate education. FAS advances knowledge, improves learning, and shapes leaders.

For more information, visit http://www.fas.harvard.edu/

CONTACT: Amgen, Thousand OaksJessica Akopyan, 805-447-0974(Media) TrishHawkins, 805-447-5631 (Media)

Harvard Faculty of Arts and Sciences, CambridgeRachael Dane, 617-456-0106 (Media)

With LabXchange's interactive lab experiments, students have access to one of the most central aspects of being a scientist: working in a laboratory.

LabXchange gives students access to a library of world-class educational videos, interactive simulations and personalized instruction to aid them in their scientific discovery.

Every student deserves an equal opportunity to prepare for and be successful in science, regardless of income, race gender or geography. LabXchange ensures this opportunity by providing students access to free online science education and inspiring lifelong learning.

LabXchange brings the experience of working and learning science in a lab straight to students. Through virtual lab experiments, high-quality videos and online collaboration with others in the global science community, students can experience the scientific process for themselves.

View original content:http://www.prnewswire.com/news-releases/free-labxchange-science-education-accelerator-launched-by-amgen-foundation-and-harvards-faculty-of-arts-and-sciences-300990930.html

SOURCE Amgen

See more here:
Free "LabXchange" Science Education Accelerator Launched By Amgen Foundation And Harvard's Faculty Of Arts And Sciences - Yahoo Finance

Read More...

2020 U.K. Molecular Diagnostics Market: Sales and Market Shares of Major Suppliers, and Profiles of Current and Emerging Companies – Yahoo Finance

Wednesday, January 22nd, 2020

This unique report provides UK sales and market share estimates for major suppliers of molecular diagnostic products. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in RandD, collaborative arrangements, and business strategies.

New York, Jan. 21, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "2020 U.K. Molecular Diagnostics Market: Sales and Market Shares of Major Suppliers, and Profiles of Current and Emerging Companies" - https://www.reportlinker.com/p05838907/?utm_source=GNW

Competitive Assessments

- Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biokit - bioMerieux - Bio-Rad - Biotest - Cepheid - Decode Genetics - Diadexus - Eiken Chemical - Elitech Group - Enzo Biochem - Exact Sciences - Fujirebio - Grifols - Hologic - Illumina - LabCorp - Leica Biosystems - Li-Cor Biosciences - Myriad Genetics - Ortho-Clinical Diagnostics - PerkinElmer - Proteome Sciences - Qiagen - Roche - Scienion - Sequenom - Shimadzu - Siemens Healthineers - Sierra Molecular - Takara Bio - Tecan Group - Thermo Fisher

List of Tables

UK Molecular Diagnostics Market by Major Supplier UK HIV/Hepatitis NAT Market Reagent Sales by Major Supplier

Contains 121 pages and 2 tables

Read the full report: https://www.reportlinker.com/p05838907/?utm_source=GNW

About ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

Clare: clare@reportlinker.comUS: (339)-368-6001Intl: +1 339-368-6001

More:
2020 U.K. Molecular Diagnostics Market: Sales and Market Shares of Major Suppliers, and Profiles of Current and Emerging Companies - Yahoo Finance

Read More...

Walking Sharks Are the Newest Branch of the Shark Family Tree – VICE

Wednesday, January 22nd, 2020

There is an entire cinematic subculture devoted to sharks that find ingenious ways to travel on land, be it via sharknado, genetic hybridization, or occult forces. Meanwhile, in the real world, there actually is a family of sharks that have evolved to walk on land, though they are much smaller, cuter, and less ravenous for human flesh than their counterparts on film.

These walking sharks belong to the Hemiscyllium family, which is the newest lineage of sharks on Earth, according to a study published on Monday in the journal Marine and Freshwater Research. Using specially adapted fins, the sharks are able to pull themselves across reefs in their tropical Indo-Australian habitat, even when they are not submerged by water.

Theyre incredibly cute little animals and are really more like a gecko walking around than a shark, said co-author Mark Erdmann, a coral reef ecologist at the California Academy of Sciences, in a call.

They are not big swimmers, added Erdmann, who also serves as vice president of the Asia-Pacific Field Division of Conservation International, an American nonprofit environmental organization. They stay on the same reef where they are born. They are very much homebodies.

While these ambulatory skills have been documented in previous studies, Erdmann and his colleagues shed new light on the familys evolutionary origins by analyzing DNA from the nine currently recognized species of Hemiscyllium. The team conducted a molecular phylogenetic analysis of the sharks, which means they used DNA sequencing to figure out the sharks genetic relationships to each other, and the wider shark lineage.

The results revealed that walking sharks are the youngest branch of the shark family tree, which dates back about 450 million years.

With our molecular clock, weve been able to show that this group really only branched off from their nearest ancestor about nine million years ago and theyve been actively radiating ever since, Erdmann said. Obviously in human terms, that still seems like a long time ago, but for sharks, and for speciation in general, thats actually very recent.

This timeline of speciation coincides with major geological changes that were occurring as the Australian continental plate slammed into landforms north of it. These tectonic processes, accompanied by volcanic eruptions, have repeatedly scrambled the region over millions of years like a giant island disco, as Erdmann described it.

Walking sharks weathered these geological storms by flourishing in newly created shallow reefs, where they gained the ability to wriggle overland to remote tidal pools. The sharks, which typically measure a foot or two in length, have also adapted to endure the oxygen depletion that occurs in these isolated pools at low tide.

But despite these amazing adaptations, walking sharks are vulnerable to natural disasters, such as tsunamis and volcanic eruptions. The fact that they have such tiny little distributionseach one has a small pocket like a bay or an archipelagomakes them just intrinsically susceptible to large perturbations and extinction events, Erdmann said.

The sharks are also increasingly facing anthropogenic pressures, including rising popularity as an aquarium attraction and potential habitat loss due to coastal development. For that reason, conservationists have been working to secure more protections for walking sharks, and have succeeded in adding three of the nine species to the International Union for Conservation of Nature Red List.

Erdmann and his colleagues plan to conduct many more expeditions to the Indo-Pacific reefs where these animals thrive, in order to learn more about their conservation requirements and the extent of their range and varieties.

The genetics very much confirm that these are a very young radiation and they seem to still be actively speciating, so we reckon that theres probably a good chance of a few more species of walking shark out there, he said. This shows to us that they very much are still an active part of our evolving planet, and thats really good news.

Read the original:
Walking Sharks Are the Newest Branch of the Shark Family Tree - VICE

Read More...

A 13-Year-Old Gave An Emotional Speech About His Dad Who Died In The Iran Plane Crash – BuzzFeed News

Monday, January 20th, 2020

Just over a week ago, 13-year-old Ryan Pourjam's father, Mansour Pourjam, died in a plane crash after Iran's government shot down the jet just outside Tehran. All 176 passengers were killed.

Iran initially blamed the Jan. 8 crash on engine failure but later admitted it was shot down in a "human error" amid heightened tensions with the US military.

On Wednesday, Ryan gave an emotional speech at a memorial service at Carleton University. His father earned his degree in biology there in 2001 and went on to become a dental technician in Ottawa, according to the Ottawa Citizen.

Ryan said his dad was an incredibly positive person who would have wanted his loved ones to remain optimistic through such a painful time.

"Hed always tell me to stay positive through the dark times and through the good, when we'd get stuck in traffic or when I couldn't get the coffee that I wanted," he said.

"I dont want to talk about the bad things," he continued. "Because I know that if my dad was alive and if someone else died in the crash and that he was right here giving a speech, he wouldn't talk about the bad stuff. I wont."

Ryan said he would describe his dad in one word as "strong."

"Hes been through tragedy after tragedy, wall after wall, wrong turn after wrong turn, and he stood strong," he said. "He was amazing, and we loved each other."

More than 200 people came to the Wednesday vigil, which was held jointly for Mansour Pourjam and another victim, Fareed Arasteh. Arasteh was a PhD student studying molecular genetics at the university, according to CBC.

Ryan said he was comforted by how many people came together to "celebrate Mansour and Fareeds amazing lives."

"I stand up here a week after this horrible tragedy, and I still cant believe it," Ryan said. "I feel like Im dreaming."

"But I know that if I was dreaming, and that if he woke me up, he'd tell me that it's going to be OK," he said. "And it will be."

Read the original:
A 13-Year-Old Gave An Emotional Speech About His Dad Who Died In The Iran Plane Crash - BuzzFeed News

Read More...

Drugs from nature: Researchers from U of T, Japan mine microbial compound library for new therapeutics – News@UofT

Monday, January 20th, 2020

Charles Boone first set foot in Japan fresh out of undergrad in 1983 when he lived and worked with a local family on a rice farm in Chiba prefecture, just outside Tokyo. There, he fell in love with many things Japanese not least its cuisine, which owes much of its flavourto fermenting microorganisms.

Now, years later, the microbes would lure Boone back to Japan, albeit for a different reason.

So many of the drugs we use today have come from microorganisms, says Boone. And theres still an enormous untapped potential out there.

Over the last decade, Boone has been working with Minoru Yoshida and Hiroyuki Osada, both professors at the RIKEN Centre for Sustainable Resource Science, to identify new compounds from microbes with the potential to be research tools and pharmaceuticals.

Another Donnelly investigator and U of T professor, Andrew Fraser, is also collaborating with the RIKEN teams to find new drugs that target parasites.

Surrounded by cherry trees on a research campus just outside Tokyo, the RIKEN Centre houses the worlds largest collection of natural compounds some 40,000 chemicals and other derivatives produced mainly by soil microbes and plants, as well as some synthetic compounds.

The RIKEN collection is exceptional because it contains so many pure natural products says Boone. This makes it easier to investigate how those molecules might be acting on living cells.

Collected by Osadas team over the last 15 years, the medical potential of the vast majority of compounds remains unexplored.

We still dont know why the microbes are producing these compounds, says Yoshida.

It could be that microbes are using these chemicals as weapons against other microbes or as communications tools, as most of them seem to be non-toxic. Whatever the reason behind their making, the researchers hope to tap into this chemistry for new molecular tools and drugs.

Its no coincidencethat Japan has such a rich resource of natural compounds. The country has a long tradition of microbial exploits in the production of food and drink. Take the rice wine sake, for example. It involves the sophisticated use of a filamentous fungus to transform pure rice into a suitable carbon source for fermentation by yeast cells.

The microbial know-how allowed Japanese scientists to discover, in the second half of the 20th century, more than 100 new antibiotics, as well as the anti-parasite blockbuster drug ivermectin, a finding that was recognized by a Nobel Prize in 2015.

Drug applications came naturally out of using microbes for food fermentation, says Yoshida, whose 1990 discovery of trichostatin A, a drug that interferes with how the DNA is packaged inside the cells, from a Streptomyces bacteriumtransformed the study of epigenetics and led to similar compounds that are being trialed on patients as a treatment for cancer and inflammation.

According to a recent study, the majority of approved medications come from nature, or are synthetic molecules inspired by the natural products. Infection-fighting antibiotics and cyclosporine, an immunosuppressant that has made transplant medicine possible, are prominentexamples.

Natural products make good drugs because they were honed by evolution to act on living cells, says Yoshida. They tend to be large and structurally diverse molecules that engage with their cellular receptors more specifically than the purely synthetic drugs, meaning they can be used at low doses and elicit fewer unwanted side effects.

Despite their clear potential, the pharmaceutical industry has shifted its focus from the natural compounds, which are also difficult to purify and synthesize on an industrial scale, to searching for drug candidates among large pools of synthetic chemicals.

But Boone thinks this may be a mistake.

It seems ridiculous to be shunning natural products given that the majority of drugs we use today have come from nature, says Boone. And our work suggests that there are a lot of compounds out there that could be useful for research and also medicine.

A 2017 study by Boone, Yoshida and Osadas teams found that the RIKEN collection holds more medically promising compounds than several stockpiles of synthetic chemicals widely used in research. They did this by identifying the molecular mechanism of action for thousands of compounds, using a large-scale application of the yeast cell-based chemical genomics platform, developed by Boones lab in the Donnelly Centre. Many of these housekeeping processes in yeast cells are also found in human cells and have been implicated in a variety of diseases, from cancer to Alzheimers.

But, there are many more compounds left to test.

More recently, Sheena Li, a post-doctoral researcher who worked in Boones lab at RIKEN, where he holds a joint appointment, and has since moved to the Donnelly Centre, found that one compound from the RIKEN collection acts as a powerful antifungal by blocking an important enzyme in yeast cells. As such, the compound holds promise for the treatment of drug-resistant fungal infections, which are becoming a serious global health threat.

Taking all their data into account, Li says they have identified about 50 products with medical potential. The next step is to check if these chemicals act in the same way in human cells.

Its a great step forward to be able to take something that you invested so much time studying in yeast into the human system, Li says.

Unlike Boone and Li, Fraser is not interested in compounds that work in human cells quite the opposite.

We want to find new drugs against intestinal parasites, he says . But we do not want to harm the humans infected with these parasites.

Gut worm parasites affect around one billion people globally, 880 million of them children, according to the World Health Organization. As the parasites are becoming resistant to frontline treatments, including ivermectin, new drugs are urgently needed.

Since ivermectin was discovered in a soil microbe, Fraser thinks theres a good chance more future treatments are to be found at RIKEN.

His team recently developed a method to screen for drugs that target an unusual type of metabolism that only exists in parasites. This type of metabolism does not require oxygen for energy production and allows parasites to survive inside the hosts body for long periods of time.

Because parasites are difficult to cultivate in the lab, Frasers team found a way to trick the harmless worm and staple research tool, C. elegans, into using the oxygen-independent metabolism and look for drugs that affect it.

Any drug candidates will only target the worms without causing harm to humans, who do not have the ability to make energy the same way as the parasites.

The next step for Fraser is to see if there any compounds in RIKENs trove that act on those targets.

The RIKEN natural product collection is like an incredible collection of intricate tools the challenge is to figure out which targets each compound affects, and how we can use them to kill pathogens and enhance our health, he says.

Read the original:
Drugs from nature: Researchers from U of T, Japan mine microbial compound library for new therapeutics - News@UofT

Read More...

Scientist Who Discovered BRCA1 Gene to Give Free Talk on Cancer And Genetics – Noozhawk

Monday, January 20th, 2020

By Caitlin O'Hara for UCSB Arts & Lectures | January 15, 2020 | 9:00 a.m.

UCSB Arts & Lectures and the Cancer Foundation of Santa Barbara co-present Understanding Genetics and Cancer, a free community event featuring Mary-Claire King, the scientist who discovered the BRCA1 gene,7:30 p.m. Thurs., Feb. 6, at UCSB Campbell Hall.

King's lecture will be followed by a panel of experts discussing genetics, cancer and you, providing resources and answering pertinent questions

UCSB Arts & Lectures and the Santa Barbara Cancer Foundation will present a free community event Understanding Genetics and Cancer, featuring a lecture by human geneticist Mary-Claire King, the scientist who discovered the BRCA1 gene.

Her talk, at 7:30 p.m. Thursday, Feb. 6, at UCSB Campbell Hall, will be followed by a panel of experts discussing genetics, cancer and you.

King discovered the genetic mutation responsible for breast cancer, a finding that has revolutionized the course of cancer research and transformed the way patients are diagnosed and treated.

A recipient of the National Medal of Science for her bold, imaginative and diverse contributions to medical science and human rights, Dr. King will discuss the genetics of inherited cancers.

Following the talk, a panel of experts will address genetics, cancer and you, including the following topics:

Lifestyle and cancer risk reductionFamily history and ethnicity risk factorsGenetic testing as cancer preventionPrivacy of genetic testing resultsBenefits and perils of ancestry testingLocal resources for cancer risk assessment and counseling

King is American Cancer Society professor in the Department of Medicine and the Department of Genome Sciences at the University of Washington in Seattle. She was the first to show that breast cancer is inherited in some families, as the result of mutations in the gene that she named BRCA1.

In addition to inherited breast and ovarian cancer, her research interests include the genetic bases of schizophrenia, the genetic causes of congenital disorders in children, and human genetic diversity and evolution.

King pioneered the use of DNA sequencing for human rights investigations, developing the approach of sequencing mitochondrial DNA preserved in human remains, then applying this method to the identification of kidnapped children in Argentina and subsequently to cases of human rights violations on six continents.

King grew up in Chicago. She received her bachelor's degree cum laude in mathematics from Carleton College in Northfield, Minn.; her doctorate in genetics from the University of California at Berkeley; and her postdoctoral training at UC San Francisco.

Her Ph.D. dissertation with Allan Wilson was the demonstration that protein-coding sequences of humans and chimpanzees are 99 percent identical. She was professor at UC Berkeley from 1976-95 and at the University of Washington in Seattle since 1995.

King has served on multiple councils and study sections of the N.I.H. and the U.S. National Academy of Sciences. She was consultant to the Commission on the Disappearance of Persons of the Republic of Argentina and carried out DNA identifications for the United Nations War Crimes Tribunals.

She is past president of the American Society of Human Genetics and a past member of the Council of the National Academy of Sciences. King has been elected to the American Academy of Arts and Sciences, the National Academy of Medicine, American Philosophical Society, and as a foreign member of the French Academy of Sciences.

Understanding Genetics and Cancer is co-presented by UCSB Arts & Lectures and the Cancer Foundation of Santa Barbara in association with Breast Cancer Resource Center, Ridley-Tree Cancer Center at Sansum Clinic, Santa Barbara Neighborhood Clinics and UCSB Department of Molecular, Cellular and Developmental Biology.

Sponsored by the Cancer Foundation of Santa Barbara, supporter of the Ridley-Tree Cancer Center and its Genetic Counseling Program.

For more, call UCSB Arts & Lectures, 805-893-3535 or visit http://www.ArtsAndLectures.UCSB.edu.

UCSB Arts & Lectures acknowledges Community Partners the Natalie Orfalea Foundation & Lou Buglioli and Corporate Season Sponsor SAGE Publishing for their support of the 2019-20 season.

Caitlin O'Hara for UCSB Arts & Lectures.

Here is the original post:
Scientist Who Discovered BRCA1 Gene to Give Free Talk on Cancer And Genetics - Noozhawk

Read More...

Genetic risk markers and misrepresentation – The Medium

Monday, January 20th, 2020

The Medium recently had the chance to sit down with Dr. EstebanParra, a molecular anthropologist and anthropology professor at the Universityof Toronto Mississauga (UTM).

Parra has hada long and far-reaching journey in science which began in one of the oldestuniversities in Spain, the University of Santiago de Compostela. He began hisstudies in biology and like many students everywhere [he] discovered what [hewas] really passionate about while completing his undergraduate degree.

For Parra, thediscovered passion was anthropology and genetics. After completing his Ph.D.degree, he completed a postdoctoral fellowship at a molecular anthropology labin Spain. He was also a post-doctoral fellow in Rome, Italy, and Pittsburgh,USA, before joining UTM in 2002. Parra advises those interested in graduatestudies to be willing to follow the opportunities that arise. For him, it hasbeen incredibly exciting to see how the UTM campus has changed and grown inthe past seventeen years. We have been attracting incredible new faculty, notonly to anthropology but to many other programs, which has been nice to see,he says.

Parra hascontinued his research at UTM. One of the focuses of his research is toidentify some of the genetic risk markers of traits and diseases such asobesity, type 2 diabetes, cardiovascular diseases, and cancer. This is doneusing a genome wide association study to identify variants that are associatedwith these traits. Parra uses a consortiaa large group of samplesto haveaccess to as much data as possible. The more samples there are, the higherchance there is of finding a common link between the genetics of an individualand the ailments they suffer from.

Parra doesmention that genetics are often not the only cause. For diseases such as cysticfibrosis, ones genes are the primary factor in causing the condition. Thesediseases are termed Mendelian disorders. However, for complex conditions likeobesity and diabetes, ones environment and lifestyle play a huge role.Modifications in your lifestyle, your diet, and physical activity, are thebest way to combat conditions such as obesity and diabetes, said Parra.

An excitingdevelopment Parra is looking forward to is the advancement of precisionmedicine. Precision medicineor personalized medicine as it is sometimesreferred tois when an individuals genetic profile can be used to develop atailor-made treatment program for the individual. Precision medicine is a newfield because it has only recently been made possible by technologicaladvancements, which have also lowered the cost of genetic studies dramatically,and, in turn, opened many doors in the field of genetics.

Parraemphasizes the importance of collecting as much data as possible. The best wayto approach this is to collaborate with other scientists [] there are somestudies that are done with many participating research groups, and they havebeen able to use samples of up to a million individuals.

One of theadvantages of collecting a large number of samples is balanced representationof diverse ethnic groups, which for Parra is very important. He explains thatgenetic studies in the past have primarily been conducted in European countrieswhich is problematic for the future of precision medicine. When you primarilywork in just one population group, it may not be as helpful for the rest of theworld, he says.

In fact, foralmost all non-European groups, underrepresentation is a significant issuewhich is only improving slowly. Underrepresentation can be attributed to avariety of factors such as biasness and the location of the research groups whogenerally choose to perform their research in their own areas. Parra encouragesthose conducting research to overcome these factors since it is absolutelycritical to do more studies and represent these groups.

Parra hascontributed in his own right to the growth of the sample pool. One of thestudies he participated in was part of a large collaboration with researchersfrom around the world. Together, the researchers collected samples from overeighteen thousand individuals of various ethnicities. Since very few studieshad been previously conducted on non-European populations, they focused onlooking for genetic markers of obesity in children. Ultimately, they discovereda new locusa fixed position on a chromosome where a genetic marker is located.The locus they had discovered had not been found in significant numbers inpurely European groups, but appeared consistently in the diverse sample pool,exemplifying the need for more diverse sources.

Despite theshortcomings, Parra is hopeful about the future of the field and its growth. Heencourages greater awareness of the disparity of samples and urges efforts torectify the misrepresentation. He is immensely passionate about anthropologyand genetics and finishes off by stating, DNA is an open bookyou just need toknow how to read it.

More:
Genetic risk markers and misrepresentation - The Medium

Read More...

Early Research Suggests Antibiotics May Be Effective in One Form of Dementia – MedicalResearch.com

Monday, January 20th, 2020

MedicalResearch.com Interview with:

Haining Zhu, PhDDepartment of Molecular and Cellular BiochemistryUniversity of Kentucky, Lexington, Kentucky

MedicalResearch.com: What is the background for this study?

Response: Frontotemporal dementia is the most common type of early onset dementia impacting people between ages 40 and 65. It affects the frontal and temporal lobes of the brain, which leads to behavior and personality changes, difficulty speaking and writing, and eventual memory deterioration.

A subgroup of patients with frontotemporal dementia have a specific genetic mutation that prevents brain cells from making a protein called progranulin. Although progranulin is not wellunderstood, its absence is linked to the disease.

MedicalResearch.com: What are the main findings?

Response: Our research team discovered that after aminoglycoside antibiotics (Gentamicin and G418) were added to neuronal cells with this mutation, the cells started making the full-length progranulin protein by skipping the mutation.

MedicalResearch.com: What should readers take away from your report?

Response: These results could be promising to drug development. Currently, there are no effective therapies for any type of dementia.This is an early stage of the study, but it provides an important proof of concept that these aminoglycoside antibiotics or their derivatives can be a therapeutic avenue for frontotemporal dementia.

MedicalResearch.com: What recommendations do you have for future research as a result of this work?

Response: After this preclinical proof of concept study, the next step is to study the antibiotics effects on mice with the mutation that causes frontotemporal dementia.If we can get the right resources and physician to work with, we could potentially repurpose the FDA-approved drug gentamicin. However, theclinical usageof Gentamicinis limited as it is associated with a number of adverse side effects. Another focus is to possibly develop new compounds from Gentamicin and G418 that could be safer and more effective.

Disclosure: A patent application based on the above results has been filed.

Citation:

Lisha Kuang, Kei Hashimoto, Eric J Huang, Matthew S Gentry, Haining Zhu.Frontotemporal dementia nonsense mutation of progranulin rescued by aminoglycosides.Human Molecular Genetics, 2020; DOI:10.1093/hmg/ddz280

We respect your privacy and will never share your details.

Last Modified: Jan 15, 2020 @ 4:36 pm

The information on MedicalResearch.com is provided for educational purposes only, and is in no way intended to diagnose, cure, or treat any medical or other condition. Always seek the advice of your physician or other qualified health and ask your doctor any questions you may have regarding a medical condition. In addition to all other limitations and disclaimers in this agreement, service provider and its third party providers disclaim any liability or loss in connection with the content provided on this website.

Post Views: 48

Read the original post:
Early Research Suggests Antibiotics May Be Effective in One Form of Dementia - MedicalResearch.com

Read More...

Why Cant Bertrand Might Cry? Missing Water Channels Could Be the Answer – Technology Networks

Monday, January 20th, 2020

Scientists at Sanford Burnham Prebys Medical Discovery Institute have shown that cells from children with NGLY1 deficiency--a rare disorder first described in 2012--lack sufficient water channel proteins called aquaporins. The discovery was published in Cell Reports and may help explain the disorder's wide-ranging symptoms--including the inability to produce tears, seizures and developmental delays--and opens new avenues to find therapies to treat the disorder.

"Our findings uncover a new and completely unexpected 'job' for NGLY1, which was originally thought to only cleave sugars from proteins," says Hudson Freeze, Ph.D., director and professor of the Human Genetics Program at Sanford Burnham Prebys and senior author of the study. "This new information, which includes the molecular signals NGLY1 uses to drive aquaporin production, fundamentally shifts how we approach drug development. Most immediately, we can begin to screen for existing FDA-approved drugs that may increase aquaporin levels."

The first patient with NGLY1 deficiency, then-four-year-old Bertrand Might, was diagnosed in 2012. The condition occurs when both copies of the NGLY1 gene contain mutations. As a result, children with NGLY1 deficiency produce little or no N-glycanase1--a protein that removes sugars from proteins during the cell's regular recycling process. Today, approximately 60 people in the world have been identified with NGLY1 deficiency. There is no cure, and existing treatments only address a few of the disorder's symptoms.

"This discovery is a giant leap forward in our understanding of NGLY1 deficiency and our ability to find a drug for the condition," says Matt Might, Ph.D., Bertrand Might's father and chief scientific officer of NGLY1.org, which funded the research. "In addition to exploring new treatment avenues, we can immediately start to test currently available drugs to see if they may help Bertrand and other children living with NGLY1 deficiency."

A surprise discovery unlocks new insights into NGLY1

Because of NGLY1's established role in helping recycle proteins, scientists predicted that cells that lack NGLY1 would fill with unrecycled proteins. However, despite numerous experiments by Freeze and others, this has not been observed.

Mitali Tambe, Ph.D., a postdoctoral associate in the Freeze lab and the first author of the study, set out to shed light on this mystery when she made an unexpected discovery. While normal cells burst open when placed in distilled water, cells from children with an NGLY1 mutation refused to pop open.

"At first I thought what every scientist initially thinks: I made a mistake," says Tambe. "But this observation actually revealed a previously unknown role for NGLY1 protein."

The unexpected finding prompted the scientists to dig in deeper. In addition to studying skin cells from three children with NGLY1 deficiency, the researchers created human and obtained mouse cells that either lacked NGLY1 or produced excess amounts of the protein. In these studies, they found that cells that lacked the NGLY1 protein had fewer aquaporins--proteins that connect the inside and outside of a cell and control water movement--and were resistant to bursting open when placed in water. These results were reversed in cells that were given excess levels of NGLY1. The researchers also identified the molecular signals NGLY1 uses to instruct cells to produce aquaporins, proteins called Atf1 and Creb1, which may lead to useful drug targets.

"In addition to regulating tear and saliva production, aquaporins are involved in many brain functions, such as cerebrospinal fluid production," explains Tambe. "Lack of aquaporins may explain many of the symptoms seen in children who are NGLY1-deficient."

The scientists devised a clever experiment to determine if NGLY1 is regulating aquaporin levels through its expected sugar-removal function or in another manner. They created two cell types that either produced a normal NGLY1 protein or NGLY1 with the sugar-cleaving area disabled. The altered protein successfully altered aquaporin levels--indicating that NGLY1 has a second function in addition to its sugar-removing (enzymatic) activities.

"Our study shows there is more to NGLY1 than its well-known function of removing sugars from proteins," says Freeze. "Together, our findings open important new paths to understanding the pathogenesis of NGLY1 deficiency and ultimately finding treatments."

Reference:Tambe, M. A., Ng, B. G., & Freeze, H. H. (2019). N-Glycanase 1 Transcriptionally Regulates Aquaporins Independent of Its Enzymatic Activity. Cell Reports, 29(13), 4620-4631.e4. https://doi.org/10.1016/j.celrep.2019.11.097

This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source.

More:
Why Cant Bertrand Might Cry? Missing Water Channels Could Be the Answer - Technology Networks

Read More...

Global Lung Cancer Diagnostics Market – Poised to Reach Over US$1.6 Billion by 2025 – ResearchAndMarkets.com – Business Wire

Monday, January 20th, 2020

DUBLIN--(BUSINESS WIRE)--The "Lung Cancer Diagnostics - Market Analysis, Trends, and Forecasts" report has been added to ResearchAndMarkets.com's offering.

The Lung Cancer Diagnostics market worldwide is projected to grow by US$1.3 Billion, driven by a compounded growth of 8%. Imaging Tests, one of the segments analyzed and sized in this study, displays the potential to grow at over 7.5%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$1.6 Billion by the year 2025, Imaging Tests will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 6.6% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$45.5 Million to the region's size and clout in the next 5 to 6 years. Over US$39.5 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Imaging Tests will reach a market size of US$85.6 Million by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 11.4% over the next couple of years and add approximately US$354.6 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders.

Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East.

Competitors identified in this market include among others:

Key Topics Covered:

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

IV. COMPETITION

For more information about this report visit https://www.researchandmarkets.com/r/9bt1jt

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

See original here:
Global Lung Cancer Diagnostics Market - Poised to Reach Over US$1.6 Billion by 2025 - ResearchAndMarkets.com - Business Wire

Read More...

Son of Iran crash victim says father ‘stood strong’ – CBC.ca

Monday, January 20th, 2020

MansourPourjam's son Ryan says his father always strived to be positive.

"I can't remember a single moment in my life where Mansour, my dad, had any trace of negativity in his voice or actions," the 13-year-old boy told a crowd of mourners Wednesday at Carleton University.

"He'd always tell me to stay positive, through the dark times and through the good, when we'd get stuck in traffic or when I couldn't get the coffee that I wanted."

More than200 people came out on Wednesday toa vigil at the university to remember bothPourjam, an Ottawa dental technician who graduated from the school,and PhD student Fareed Arasteh both victims in last week's crashof Ukraine International Airlines Flight PS752 outside Tehran.

Iran's Revolutionary Guard shot down the aircraft on Jan. 8,killingall 176 passengers and crew members including 57 Canadian citizens.

Mansour Pourjam had been working at the Ottawa Denture andImplant Centrein Bells Corners at the time of his death.

"If I could describe [my father] in one word, it would be strong. He's been through tragedy after tragedy, wall after wall, wrong turn after wrong turn and he's stood strong," his son said, as people in the audience wiped their eyes.

"He was amazing. We loved each other."

Arasteh, meanwhile, was performingPhDresearch atthe university's biology department, where he was studying molecular genetics. He'dreturned to Iran for the holidays to marry his long-time girlfriend.

His close friend and roommate Reza Sananfartold the crowd Arastehwas a "dreamer" who worked hard to achieve his goals and would also help his friends fulfil their own dreams.

"Although Fareed didn't get to spend much time here at Carleton, I can see that he touched so many lives while he was walking among us here," Sananfar said.

"I thought talking about him would help me to accept the fact that he is not coming back. But there are no words that can ease the pain, or fill the void that many of us are feeling inside us."

Carleton University president Benoit-Antoine Bacon saidit was important to have this gathering to help the community grieve and begin to heal.

Universities across the country paused to honourthe victims Wednesday,as many of the passengers on the flightwerestudents, faculty members and researchers.

The University of Ottawa has said that threeof the victims were students there, while Queen's University has confirmed one of its undergraduate students died in the crash.

See more here:
Son of Iran crash victim says father 'stood strong' - CBC.ca

Read More...

The biology of coffee, the world’s most popular drink – EconoTimes

Monday, January 20th, 2020

Youre reading this with a cup of coffee in your hand, arent you? Coffee is the most popular drink in the world. Americans drink more coffee than soda, juice and tea combined.

How popular is coffee? When news first broke that Prince Harry and Meghan were considering Canada as their new home, Canadian coffee giant Tim Hortons offered free coffee for life as an extra enticement.

Given coffees popularity, its surprising how much confusion surrounds how this hot, dark, nectar of the gods affects our biology.

Coffees ingredients

The main biologically active ingredients in coffee are caffeine (a stimulant) and a suite of antioxidants. What do we know about how caffeine and antioxidants affect our bodies? The fundamentals are pretty simple, but the devil is in the details and the speculation around how coffee could either help or harm us runs a bit wild.

The stimulant properties of caffeine mean that you can count on a cup of coffee to wake you up. In fact, coffee, or at least the caffeine it contains, is the most commonly used psychoactive drug in the world. It seems to work as a stimulant, at least in part, by blocking adenosine, which promotes sleep, from binding to its receptor.

Caffeine and adenosine have similar ring structures. Caffeine acts as a molecular mimic, filling and blocking the adenosine receptor, preventing the bodys natural ability to be able a rest when its tired.

This blocking is also the reason why too much coffee can leave you feeling jittery or sleepless. You can only postpone fatigue for so long before the bodys regulatory systems begin to fail, leading to simple things like the jitters, but also more serious effects like anxiety or insomnia. Complications may be common; a possible link between coffee drinking and insomnia was identified more than 100 years ago.

The National Film Board of Canada produced a documentary on the cultural history of coffee called Black Coffee: Part One, The Irresistible Bean

Unique responses

Different people respond to caffeine differently. At least some of this variation is from having different forms of that adenosine receptor, the molecule that caffeine binds to and blocks. There are likely other sites of genetic variation as well.

There are individuals who dont process caffeine and to whom drinks like coffee could pose medical danger. Even away from those extremes, however, there is variation in how we respond to that cup of coffee. And, like much of biology, that variation is a function of environment, our past coffee consumption, genetics and, honestly, just random chance.

We may be interested in coffee because of the oh-so-joyous caffeine buzz, but that doesnt mean that caffeine is the most biologically interesting aspect of a good cup of coffee.

In one study using rats, caffeine triggered smooth muscle contraction, so it is possible that caffeine directly promotes bowel activity. Other studies, though, have shown that decaffeinated coffee can have as strong an effect on bowel activity as regular coffee, suggesting a more complex mechanism involving some of the other molecules in coffee.

Antioxidant benefits

What about the antioxidants in coffee and the buzz that surrounds them? Things actually start out pretty straightforward. Metabolic processes produce the energy necessary for life, but they also create waste, often in the form of oxidized molecules that can be harmful in themselves or in damaging other molecules.

Antioxidants are a broad group of molecules that can scrub up dangerous waste; all organisms produce antioxidants as part of their metabolic balance. It is unclear if supplementing our diet with additional antioxidants can augment these natural defences, but that hasnt stopped speculation.

Antioxidants have been linked to almost everything, including premature ejaculation.

Are any of the claims of positive effects substantiated? Surprisingly, the answer is again a resounding maybe.

Coffee and cancer

Coffee wont cure cancer, but it may help to prevent it and possibly other diseases as well. Part of answering the question of coffees connection to cancer lies in asking another: what is cancer? At its simplest, cancer is uncontrolled cell growth, which is fundamentally about regulating when genes are, or are not, actively expressed.

My research group studies gene regulation and I can tell you that even a good cup of coffee, or boost of caffeine, wont cause genes that are turned off or on at the wrong time to suddenly start playing by the rules.

The antioxidants in coffee may actually have a cancer-fighting effect. Remember that antioxidants fight cellular damage. One type of damage that they may help reduce is mutations to DNA, and cancer is caused by mutations that lead to the misregulation of genes.

Studies have shown that consuming coffee fights cancer in rats. Other studies in humans have shown that coffee consumption is associated with lower rates of some cancers.

Interestingly, coffee consumption has also been linked to reduced rates of other diseases as well. Higher coffee consumption is linked to lower rates of Parkinsons disease and some other forms of dementia. Strikingly, at least one experimental study in mice and cell culture shows that protection is a function of a combination of caffeine and antioxidants in coffee.

Higher coffee consumption has also been linked to lower rates of Type 2 diabetes. Complexity, combined effects and variation between individuals seems to be the theme across all the diseases.

At the end of the day, where does all this leave us on the biology of coffee? Well, as I tell my students, its complicated. But as most reading this already know, coffee will definitely wake you up in the morning.

Go here to read the rest:
The biology of coffee, the world's most popular drink - EconoTimes

Read More...

11 Year-Old Bertrand Might Cant Cry Scientists Have Now Discovered Why – SciTechDaily

Monday, January 20th, 2020

11-year-old Bertrand Might (center) surrounded by his family, including his father, Matt Might (second from right), and his mother, Cristina Might (second from left). Credit: The Might family

Scientists at Sanford Burnham Prebys Medical Discovery Institute have shown that cells from children with NGLY1 deficiency a rare disorder first described in 2012 lack sufficient water channel proteins called aquaporins. The discovery was published in Cell Reports and may help explain the disorders wide-ranging symptoms including the inability to produce tears, seizures and developmental delays and opens new avenues to find therapies to treat the disorder.

Our findings uncover a new and completely unexpected job for NGLY1, which was originally thought to only cleave sugars from proteins, says Hudson Freeze, Ph.D., director, and professor of the Human Genetics Program at Sanford Burnham Prebys and senior author of the study. This new information, which includes the molecular signals NGLY1 uses to drive aquaporin production, fundamentally shifts how we approach drug development. Most immediately, we can begin to screen for existing FDA-approved drugs that may increase aquaporin levels.

Burst cells are shown in orange, and intact cells are shown in blue (the dye used stains the DNA in a nucleus). Unlike normal cells (left), cells missing the NGLY1 protein (right) refused to split open when placed in distilled water. The cells pictured are from mice. Credit: Sanford Burnham Prebys

The first patient with NGLY1 deficiency, then-four-year-old Bertrand Might, was diagnosed in 2012. The condition occurs when both copies of the NGLY1 gene contain mutations. As a result, children with NGLY1 deficiency produce little or no N-glycanase1 a protein that removes sugars from proteins during the cells regular recycling process. Today, approximately 60 people in the world have been identified with NGLY1 deficiency. There is no cure, and existing treatments only address a few of the disorders symptoms.

This discovery is a giant leap forward in our understanding of NGLY1 deficiency and our ability to find a drug for the condition, says Matt Might, Ph.D., Bertrand Mights father and chief scientific officer of NGLY1.org, which funded the research. In addition to exploring new treatment avenues, we can immediately start to test currently available drugs to see if they may help Bertrand and other children living with NGLY1 deficiency.

Because of NGLY1s established role in helping recycle proteins, scientists predicted that cells that lack NGLY1 would fill with unrecycled proteins. However, despite numerous experiments by Freeze and others, this has not been observed.

Hudson Freeze, Ph.D., director and professor of the Human Genetics Program at Sanford Burnham Prebys and senior author of the study. Credit: Sanford Burnham Prebys

Mitali Tambe, Ph.D., a postdoctoral associate in the Freeze lab and the first author of the study, set out to shed light on this mystery when she made an unexpected discovery. While normal cells burst open when placed in distilled water, cells from children with an NGLY1 mutation refused to pop open.

At first I thought what every scientist initially thinks: I made a mistake, says Tambe. But this observation actually revealed a previously unknown role for NGLY1 protein.

The unexpected finding prompted the scientists to dig in deeper. In addition to studying skin cells from three children with NGLY1 deficiency, the researchers created human and obtained mouse cells that either lacked NGLY1 or produced excess amounts of the protein. In these studies, they found that cells that lacked the NGLY1 protein had fewer aquaporins proteins that connect the inside and outside of a cell and control water movement and were resistant to bursting open when placed in water. These results were reversed in cells that were given excess levels of NGLY1. The researchers also identified the molecular signals NGLY1 uses to instruct cells to produce aquaporins, proteins called Atf1 and Creb1, which may lead to useful drug targets.

In addition to regulating tear and saliva production, aquaporins are involved in many brain functions, such as cerebrospinal fluid production, explains Tambe. Lack of aquaporins may explain many of the symptoms seen in children who are NGLY1-deficient.

The scientists devised a clever experiment to determine if NGLY1 is regulating aquaporin levels through its expected sugar-removal function or in another manner. They created two cell types that either produced a normal NGLY1 protein or NGLY1 with the sugar-cleaving area disabled. The altered protein successfully altered aquaporin levels indicating that NGLY1 has a second function in addition to its sugar-removing (enzymatic) activities.

Our study shows there is more to NGLY1 than its well-known function of removing sugars from proteins, says Freeze. Together, our findings open important new paths to understanding the pathogenesis of NGLY1 deficiency and ultimately finding treatments.

Reference: N-Glycanase 1 Transcriptionally Regulates Aquaporins Independent of Its Enzymatic Activity by Mitali A. Tambe, Bobby G. Ng and Hudson H. Freeze, 24 December 2019, Cell Reports.DOI: 10.1016/j.celrep.2019.11.097

Research reported in this article was supported by the Bertrand Might Research Fund and NGLY1.org. Additional study authors include Bobby Ng.

Here is the original post:
11 Year-Old Bertrand Might Cant Cry Scientists Have Now Discovered Why - SciTechDaily

Read More...

Science Talk – Tell me more about telomeres: how ‘basic’ science can help us treat cancer – The Institute of Cancer Research

Monday, January 20th, 2020

Image: Chromosomes and their telomeres (visualised in red). Credit: Thomas Ried, NCI Center for Cancer Research

You might not have heard of telomeres but theyre incredibly important they are the caps that protect the end of chromosomes. They work like the plastic tips that stop your shoelaces from fraying.

All cancers alter telomeres in order to survive, so by doing basic research to try to understand how telomere replication and processing works, Max and his team hope to identify possible new ways to target and treat cancer.

Having joined the Division of Cancer Biology in October 2019, Dr Max Douglasis now one of the newest Team Leaders at the ICR. I met him at our Chester Beatty Laboratories in Chelsea, where he told me more about his work.

Max studied for his PhD in biochemistry and cell biology at the University of Cambridge. He then joined Dr John Diffleys team in Londons Clare Hall Laboratories which later became part of the Francis Crick Institute where he focused on studying the early stages of DNA replication.

At the Crick, he helped establish in detail how a protein complex called the CMG replicative helicase that helps unwind DNA during replication, is assembled and activated.

Now at the ICR, Max leads his own research team studying DNA replication but in the context of telomeres and cancer.

My main project is to rebuild telomeres in the lab and then unpick how they work how they are replicated and how they are processed. This knowledge is generally useful, but we will focus on studying it in the context of cancer, explained Max.

Lets finish it:help us revolutionise cancer treatment. We aim to discover a new generation of cancer treatments so smart and targeted, that more patients will defeat their cancer and finish what they started.

Support our work

When a cell becomes cancerous, it divides more often and every time it divides, its telomeres become shorter and shorter. Once there is no telomere left, the DNA unravels, like a shoelace fraying, and the cell dies. This eventually happens in most healthy cells telomeres shorten over time until cell division is no longer possible, leading to cell death.

While this loss of telomere protection can cause cancer cells and healthy cells to die, it can also lead to a state of genome instability that helps cancer survive and spread.

We also know that cancer cells can escape death by making telomerase, an enzyme that prevents telomeres from getting short. Certain cells in our body, such as stem cells, are able to divide over and over again thanks to telomerase. Cancer cells take advantage of this enzyme and hijack it to maintain telomere length which enables them to continue to divide and spread.

In other words, telomeres seem to play a role in the death of cancer cells but theyre also crucial for their survival. However, the molecular steps that guide telomere replication and processing remain poorly understood.

By using genetics and replicating cellular processes in a test tube, through a technique known as reconstitution biochemistry, Max and his team hope to better understand how telomeres are processed, and how they are inherited from one generation of cells to the next.

If Max and his team can dissect how telomeres work and clarify their link to cancer, maybe well figure out new ways to treat it.

His research might seem quite distant from the clinic, but Max knows he belongs at the ICR, which has an exemplary track record in making discoveries that ultimately benefit people with cancer.

I really value the ICRs commitment to doing basic, laboratory science. Good basic science is necessary to understand cancer, and the ICR values that. Here, I can figure out how to use my findings to benefit people, and that, in turn, will also hugely benefit my work, Max said.

I feel very lucky to work at an institution with a mission, being able to do what I love while getting opportunities to make discoveries that could help people.

As a new Team Leader, Max is currently the only member of his team but a higher scientific officer will be joining this month, as well as a post-doctoral training fellow, who will be joining in March. They will also start recruiting for a PhD student. As he told me, he cant wait for the new team members to join him in January.

Im excited to supervise other people for the first time. I want to build a strong team and a good environment for them to thrive in.

View original post here:
Science Talk - Tell me more about telomeres: how 'basic' science can help us treat cancer - The Institute of Cancer Research

Read More...

Six City Honors grads in Jacobs School Class of 2023 – UB Now: News and views for UB faculty and staff – University at Buffalo Reporter

Wednesday, January 8th, 2020

They spent their middle school and high school years with a firsthand view of the development of the burgeoning Buffalo Niagara Medical Campus, including the sparkling new downtown building that houses the Jacobs School of Medicine and Biomedical Sciences.

Now, amazingly, six graduates of City Honors School find themselves in the Class of 2023 at the Jacobs School.

These first-year students Hani Al-Jabi-Lopez, Lillian Dixon, James Ghosen, Fiona Hennig, Aleena Jafri and Joseph Nathanson are all alumni of the prestigious Buffalo school adjacent to the BNMC that routinely shows up in rankings of the best public schools in the state and even the country.

Hennig graduated from City Honors in 2012 and Dixon in 2015, while the others graduated in 2014. All six were enrolled in the International Baccalaureate Diploma Program, a program that prepares students in high school for the rigors of college.

City Honors is one of our stronger inner city schools, so its not a surprise that they are preparing students that eventually end up in medical school, says Dori R. Marshall, associate dean and director of admissions. Our hope is that we can help foster relationships with other high schools through our pipeline programs so the other Buffalo public schools also see that success with students.

The Jacobs School does not break out official statistics for the high schools its medical classes attended. However, James J. Rosso, admissions adviser in the Office of Medical Admissions, says that in the past 25 years, there have not been that many graduates of one high school in a single medical class at the Jacobs School.

The six are adjusting well, and have been impressed with the faculty and staff, and the new building that houses the medical school.

The professors and the deans really care about you doing well, and really try to help us out if were struggling, says Al-Jabi-Lopez, who earned bachelors degrees in behavioral biology and Spanish from Johns Hopkins University in 2018.

The facilities are also very impressive, adds Al-Jabi-Lopez, who plans to work in a clinical setting after residency and is also interested in academic medicine.

After graduating from Cornell University in 2016 with a bachelors degree in biology, Hennig moved to Oakland, Calif., and spent three years working and enjoying some time off before applying to medical school.

Therefore, all my fellow Centaurs (the schools mascot) were two or three grades below me in high school, she says. We knew of each other but now, being in the same medical school class, I have gotten to know each of them a little bit more.

I think it is no surprise that City Honors graduates excel in whatever they choose to pursue, she adds. I personally am very fortunate to have had many resources throughout my high school and undergraduate career, including a loving, supportive family.

The Jacobs School is also given high marks.

I really like the environment that the deans and faculty have created. I feel lucky to be in this high-tech facility, says Hennig, who has been especially impressed with the anatomy lab, which is not uncommon for current and prospective students.

After medical school, she hopes to pursue a surgical residency.

My goal is to become a surgeon specializing in gender-affirming surgeries for the LGBTQ+ community, she says. I hope to make an impact on the future of medical education and curriculum, and bring more awareness to LGBTQ+ health care wherever I end up.

Dixon, who earned bachelors degrees in molecular genetics and psychology from SUNY Fredonia in 2019, also finds the Jacobs School a nice fit.

The environment here is supportive and a lot more relaxed than other medical schools that Ive seen, she says. Its more focused on our health and happiness.

Ghosen and Nathanson have been good friends since they arrived at City Honors in fifth grade.

More than anything, City Honors prepares its students for the rigors of undergraduate life, and this in turn enables us to pursuecompetitive fields of study, Ghosen says. Many of the premedical students I met in college had never been exposed to such a large and difficult workload, and coming from City Honors, the transition wasnt as difficult.

Ghosen, who earned a bachelors degree in biology from SUNY Geneseo in 2018, enjoys the collaborative atmosphere at the Jacobs School.

The workload is definitely an adjustment from undergrad, but everybody in the class has been really great, he says. Its not cutthroat everybody kind of works together and that helps.

And he can think of nothing better than staying in his hometown after he gets his degree and completes his residency.

I definitely plan to practice in the Buffalo area, and could one day see myself teaching medical students from the Jacobs School, Ghosen says.

Thats music to Marshalls ears.

Whether they do their residency here or somewhere else, our hope is that they will come back here and make this their home because there is a physician shortage here, says Marshall, whos also an associate professor of psychiatry. We need our graduates to stay here and work.

Nathanson, who earned bachelors degrees in biological sciences and psychology from UB in 2018, appreciates the solid academic foundation that has prepared him for medical school.

I think that City Honors is second to none when it comes to preparing their students for furthering their education in an advanced setting, says Nathanson, who hopes to one day run his own medical practice. I was lucky enough to already know how to study before getting to college, and have carried some of those same techniques that I used in high school all the way to medical school.

Jafri, who earned a bachelors degree in biology from Cornell University in 2018, also likes being back in her hometown.

I chose the Jacobs School because of family and friends living in the city, because Buffalo is home, and also because this school offers a truly high-quality medical education with programs and opportunities in areas that are of interest to me, she says. The tremendous developmentof the surrounding medical complex and the many hospitals affiliated with the university were also a big plus.

They are continually making adjustments to the curriculum to improve the quality of our education and to cultivate a good environment that doesnt lead to burnout, Jafri adds.

William Kresse, principal at City Honors, says there has been an upswing in students from the school headed into STEM (science, technology, engineering and mathematics) fields over the past decade, and notes that City Honors has also expanded its intensive four-year science research program at the BNMC.

We are excited that so many of our alums are making their way to the Jacobs School, Kresse says.

More here:
Six City Honors grads in Jacobs School Class of 2023 - UB Now: News and views for UB faculty and staff - University at Buffalo Reporter

Read More...

Nature Reviews Genetics Pseudogene Function Is Prematurely Dismissed – Discovery Institute

Wednesday, January 8th, 2020

A new paper in Nature Reviews Genetics, Overcoming challenges and dogmas to understand the functions of pseudogenes, is simply incredible. It documents not only that pseudogenes have been found to have widespread function but also that under current dogma in biology, and given the technical limitations, we are failing to recognize their functions. As Seth W. Cheetham and his co-authors put it, biology suffers from demotivation into exploring pseudogene function by the a priori assumption that they are functionless where The dominant limitation in advancing the investigation of pseudogenes now lies in the trappings of the prevailing mindset that pseudogenic regions are intrinsically non-functional.

The abstract lays out exactly what they think:

Pseudogenes are defined as regions of the genome that contain defective copies of genes. They exist across almost all forms of life, and in mammalian genomes are annotated in similar numbers to recognized protein-coding genes. Although often presumed to lack function, growing numbers of pseudogenes are being found to play important biological roles. In consideration of their evolutionary origins and inherent limitations in genome annotation practices, we posit that pseudogenes have been classified on a scientifically unsubstantiated basis. We reflect that a broad misunderstanding of pseudogenes, perpetuated in part by the pejorative inference of the pseudogene label, has led to their frequent dismissal from functional assessment and exclusion from genomic analyses. With the advent of technologies that simplify the study of pseudogenes, we propose that an objective reassessment of these genomic elements will reveal valuable insights into genome function and evolution.

They immediately caution that there are many instances where DNA that was dismissed as pseudogene junk was later found to be functional: with a growing number of instances of pseudogene-annotated regions later found to exhibit biological function, there is an emerging risk that these regions of the genome are prematurely dismissed as pseudogenic and therefore regarded as void of function.

In 2003, Francisco Ayala and Evgeniy Balakirev wrote in Annual Review of Genetics that pseudogenes that have been suitably investigated often exhibit functional roles. This new Nature Reviews Genetics paper offers a very similar statement: Where pseudogenes have been studied directly they are often found to have quantifiable biological roles. Its a long narrative that recounts how many scientists mistakenly dismissed stretches of DNA as pseudogenes. They document dozens of instances where pseudogenes in humans and other organisms have been found to have function.

Some of these functions are protein-based, meaning the pseudogene actually generates a functional protein. But other functions can be RNA-based or DNA-based. For example, most evolutionists would presume that a pseudogene that does not produce a protein cant be functional. But the paper observes that pseudogenes that cannot be translated into a protein may still have a function through their RNA transcript:

Many pseudogenes contain a frequency of mutations that render them unlikely to be (or incapable of being) translated into proteins. However, such mutations do not necessarily preclude pseudogenes from performing a biological function.

The paper notes that even if the RNA transcript of a pseudogene cant be translated into protein, a myriad of RNA-based regulatory mechanisms have been described for pseudogenes, including processing into small interfering RNAs (siRNAs) that may regulate their parent genes, acting as a decoy for transcription factors and, most prominently, as molecular sponges for microRNAs.

Many evolutionists would forcefully assume that if a pseudogene cant even produce an RNA transcript then it cant be functional. But it turns out that pseudogenes that dont produce any RNA transcript (i.e., arent transcribed) can still have important functions:

Another mechanism through which pseudogenes can function is by influencing chromatin or genomic architecture. HBBP1, a pseudogene residing within the haemoglobin locus, enables the dynamic chromatin changes that regulate expression of fetal and adult globin genes during development. Notably, although inhibiting HBBP1 transcription has no effect, deletion of the genomic locus reactivates fetal globin expression. HBBP1 DNA contacts, but not transcription, are required for suppressing the expression of fetal globin genes in adult erythroid cells.

A variety of other non-transcriptional functions are documented in the paper, including stabilizing chromosomes, mediating transcript-splicing, and regulating recombination. Thus, in many cases copy numbers of pseudogenes seem to have functional importance, where deviations from the normal genetic state causes disease. They predict: It is expected that further links between human pseudogene polymorphisms and complex diseases will be identified in the coming years

The implication is that one reason we presume pseudogenes are functionless is because we havent been looking for their functions. And why didnt we look for their functions? Because we presumed they were functionless! So theres a circular aspect to the reasoning here. It has created the science-stopping junk-DNA paradigm, which has prevented us from understanding what pseudogenes really do.

The typical response from evolutionists would be that all of these examples of functional pseudogenes are just isolated rare cases, and that the bulk of pseudogenes are clearly junk. The authors of the paper who give no indication of sympathy for intelligent design, but definitely oppose dismissing pseudogenes as junk are aware of this objection. They say the following in direct rebuttal to it:

The examples of pseudogene function elaborated on here should not imply that pseudogene functionality is likely to be confined to isolated instances. At least 15% of pseudogenes are transcriptionally active across three phyla, many of which are proximal to conserved regulatory regions. It is estimated that at least 63 new human-specific protein-coding genes were formed by retrotransposition since the divergence from other primates. Numerous retrogenes continue to be recognized as functional protein-coding genes rather than pseudogenes across species. High-throughput mass spectrometry and ribosomal profiling approaches have identified hundreds of pseudogenes that are translated into peptides. Although the functions of these peptides remain to be experimentally determined, such examples illustrate the challenge in substantiating a genepseudogene dichotomy.

They continue: As the abundance of such [non-coding-DNA] acquired functions does not appear to be an especially rare or isolated phenomenon, it would seem remiss to take the default perspective that processed pseudogenes are functionless. Instead, it is probable that pseudogene-containing regions of the genome harbour important biological functions that are yet to be revealed.

They point out that current algorithmic and computational methods employed for differentiating pseudogenes and protein-coding genes may overestimate the proportion of the genome that is composed of pseudogenes. Why? Because the properties that are used to define many pseudogenes are also often found in normal protein-coding genes. For example:

Because of this, they argue that computational differentiation of pseudogenes from genes on a purely rule-based system is unlikely to be feasible as it will inherently conflict with many protein-coding genes. They therefore propose markedly softening claims that a stretch of DNA is a pseudogene: it may be useful to consider the annotation of pseudogenes in genomes as a prediction or a hypothesis rather than a classification.

As the authors show, the presumption that a pseudogene is functionless needs to be abandoned. But then, why are we still presuming they are functionless? There are three main reasons: (1) evolutionary thinking has presumed that pseudogenes are functionless junk, (2) terminological dogma reinforces a mindset that pseudogenic regions are intrinsically non-functional, and (3) technological limitations prevent us from discovering their function. The paper acknowledges that problem (3) stems from problem (2), but it fails to explicitly recognize that both problems (2) and (3) ultimately stem from problem (1). In fact it doesnt even identify problem (1) as a problem. Yet the whole situation traces back to bad evolutionary predictions. Lets look at these causes briefly, in reverse order:

The proximal cause that prevents us from understanding pseudogene functions are technological limitations. Because of the junk DNA paradigm, a lot of our biochemical techniques and technologies are set up only to identify standard protein-coding genes. They ignore and dismiss DNA that doesnt fit that mold. Only by updating our technology to detect functional DNA elements that dont necessarily fit the standard definition of a gene can be we begin to understand what pseudogenes really do. The paper explains that technical limitations, informed by our biases and assumptions, demotivate the study of pseudogene functions:

In addition to the demotivation into exploring pseudogene function by the apriori assumption that they are functionless, their systematic study has also been hindered by a lack of robust methodologies capable of distinguishing the biological activities of pseudogenes from the functions of the genes from which they are derived.

They compare the situation to that of long non-coding RNAs (lncRNAs), which were similarly dismissed initially as emanating from junk DNA or as transcriptional noise, largely by virtue of their definition as non-protein-coding. But as technology developed, lncRNAs are now widely recognized as functional and we regularly screen for their functions:

Following a combination of technology developments, genome-wide studies and detailed biochemical studies, lncRNAs are now routinely included in genome-wide analyses, and their functional potential as cellular regulators is widely recognized.

However, at present, the authors note, due in part to the experimental challenge of investigating their function and expression, pseudogenes are typically excluded from genome-wide functional screens and expression analyses. In other words, one of the main reasons we arent finding function for pseudogenes is because we arent looking for it. This needs to change, and they argue that it can.

For example, according to the paper, processed pseudogenes were presumed to have been rendered transcriptionally silent by the loss of cis-regulatory elements. But we now know that thousands of retrotransposed gene copies are transcribed and are often spliced into known protein-coding transcripts and up to 10,000 mouse pseudogenes have evidence of transcription. By trying to study these transcripts we can understand what they may be doing.

One complication is that pseudogene transcription shows cell-type specificity and dynamic expression meaning they may only be transcribed in particular places at particular times. This is all the more reason not to assume that lack of evidence for the function of a pseudogene is evidence that the pseudogene has no function! It very likely may be functional in a cell-type or a situation that we just havent properly investigated yet. As they put it, The use of assays ill-suited to analysis of pseudogenes has arguably stymied elucidation of their biological roles. But they are hopeful: CRISPR-based approaches, carefully applied, have the potential to revolutionize our ability to dissect the functions of pseudogenes. They conclude that its time to stop excluding pseudogenes from biochemical analyses and start using techniques that can identify their functions:

The use of a liberal definition of pseudogenes is attractive as it simplifies genomic analyses. This approach, often unknowingly to the researcher, leads to the consolidation of the pseudogene classification that is, their exclusion by convenience in functional studies. Many regions now considered to be dead genes potentially encode cis-regulatory elements, non-coding RNAs and proteins with impacts in human biology and health. Accordingly, determining the functions of putative pseudogenes warrants active pursuit by their inclusion in functional screens and analyses of genomic, transcriptomic and proteomic data. With innovations in long-read sequencing and CRISPR-based methodologies now readily accessible, the technological limitations that formerly motivated the exclusion from functional investigation are largely resolved.

Until we develop and apply these technologies to put pseudogenes to the proper test, the assumption that they are functionless junk is completely unwarranted. And its not hard to predict what the outcome will be. As Ayala and Balakirev noted, pseudogenes that have been suitably investigated often exhibit functional roles. Or as this new paper observes, Where pseudogenes have been studied directly they are often found to have quantifiable biological roles.

Technology only reflects what people want to do, and there are reasons why biologists have created hardly any technology to investigate pseudogenes: biologists presume (wrongly) that pseudogenes are nonfunctional junk. The paper argues that the terminology associated with the junk DNA paradigm discourages investigation into their function. Thus, we have terms like pseudogene which by their very nature imply that the DNA isnt a gene but something like a wannabe gene that doesnt do anything. As the authors note, the definition of a pseudogene as defective means the non-functionality of pseudogenes remains the dominant and default perception. Citing Thomas Kuhn and his concept of a dominant paradigm that is intolerant of criticisms, they lash the junk-pseudogene paradigm in strong terms:

[T]he term pseudogene itself asserts a paradigm of non-functionality through its taxonomic construction. Pseudogenes are defined as defective and not genes. This point is highlighted because impartial language in science is known to inherently restrict the neutral investigation between conflicting paradigms. In the case of pseudogenes, the term itself is constructed to support the dominant paradigm and therefore limit, consciously or unconsciously, scientific objectivity in their investigation.

Its hard to imagine a greater indictment of the idea that pseudogenes are generally functionless. They continue to explain how use of the term pseudogene hinders scientific research:

Although the pseudogene concept arose to describe an individual molecular phenomenon, the term was rapidly adopted to annotate tens of thousands of genomic regions that met only loosely defined criteria and was effectively axiomatized without being subject to any rigorous scientific debate. This lack of consensus-seeking process has left genome biology with a legacy concept that obscures objective investigation of genome function.

They recommend using different language where [t]he automated classification of gene-like sequences as pseudogenes should be avoided. Instead, we propose that descriptive terms that do not make functional inferences should be used in reference to genomic elements that arose from gene duplication and retrotransposition and terminology should not impose any unsubstantiated assumption on end users.

So what is now stopping us from elucidating the functions of pseudogenes? The only obstacle is a mental block not a technical or evidential one:

The dominant limitation in advancing the investigation of pseudogenes now lies in the trappings of the prevailing mindset that pseudogenic regions are intrinsically non-functional.

The paper predicts that as soon as we lose this mindset, there will remain no technical limitations blocking us from progress in understanding the functions of pseudogenes: With renewed scientific objectivity, we anticipate that a wealth of discoveries to understand genome function, its role in disease and the development of new treatments is within reach.

Thats good news, but we must ask a question the paper fails to ask: Why did this terminology develop in the first place?

Evolutionary thinking is the cause that ultimately created, nurtured, and sustained the junk DNA paradigm. Yet the paper adopts a wholly evolutionary approach, and for this reason never identifies evolutionary thinking as the root problem. The closest the authors get is when they recount how the very first paper to identify a pseudogene (published in 1977) dismissed its potential function as a relic of evolution:

In the absence of evidence that the 5S pseudogenes were transcribed, Jacq etal. concluded that the most probable explanation for the existence of the pseudogenes is that they are a relic ofevolution and are functionless1. Since the coining of the term pseudogene, its definition has broadened and is now widely accepted to define any genomic sequence that is similar to another gene and is defective.

This 1977 paper by Jacq et al. was published in the journal Cell and found a pseudogene in an African frog. That paper concluded:

We are thus forced to the conclusion that the most probable explanation for the existence of the pseudogene is that it is a relic of evolution. During the evolution of the 55 DNA of Xenopus laevis, a gene duplication occurred producing the pseudogene. Presumably the pseudogene initially functioned as a 55 gene, but then, by mutation, diverged sufficiently from the gene in its sequence so that it was no longer transcribed into an RNA product.

And there you have it: The pseudogene is seen as a mere a relic produced by mutation until it diverged so much that it was no longer transcribed into an RNA product. This is the classic view of a pseudogene.

Ironically, the 1977 paper went on to speculate that perhaps there is evidence for function for the pseudogene, but the authors privilege the relic view as the right answer until a function can be proven:

This evolutionary explanation for the presence of the pseudogene, however, is incomplete by itself in that it ignores the conservation in sequence of the pseudogene, and indeed of the entire G + C-rich spacer of 55 DNA. In an attempt to explain this, it has been suggested that the pseudogene may be a transcribed spacer corresponding to a primary transcript of 55 RNA, which is a transient precursor and has not so far been detected. If this is so, then most of the G + C-rich region of 55 DNA would be the structural gene for 5S RNA. This function, if true, would provide the necessary selective pressure to conserve the sequence of the linker and pseudogene region so that the correct processing of the postulated 300-long precursor was maintained. In the absence of any experimental evidence for such a long precursor, however, this suggestion must be regarded as speculative; it is more probable that the pseudogene is a relic of evolution.

The recent Nature Reviews Genetics paper hopes to remedy this problem by reviewing much of the overwhelming evidence for pseudogene function and emphasizing how the the non-functionality of pseudogenes remains the dominant and default perception. This will limit, consciously or unconsciously, scientific objectivity in their investigation. The authors are to be commended. However, experience teaches that unless you address the root cause of a problem, it rarely goes away. The tendency to view pseudogenes as a relic of evolution probably wont change as long as you presume that the entire genome is the product of blind evolution. The paper fully endorses the latter view, providing all kinds of narrative gloss that describes pseudogenes (whether functional or not) as retrocopies that arose from gene duplication and transposition. They emphasize:

In the fundamental reductionist approach often assumed in genetics and molecular biology, the perspective is often lost that life as we observe it today is not only the product of billions of years of evolutionary processes but also still subject to these same processes.

They are welcome to take the reductionist approach often assumed in genetics and molecular biology. But until those fundamental evolutionary views of the genome are on the table for questioning, they wont make much progress in shaking the science-stopping assumptions of the junk-DNA paradigm.

Photo: Xenopus laevis, by Brian Gratwicke [CC BY 2.0], via Wikimedia Commons.

Excerpt from:
Nature Reviews Genetics Pseudogene Function Is Prematurely Dismissed - Discovery Institute

Read More...

Scientists link mysterious snippets of DNA to cell growth and tumor suppression – GeekWire

Wednesday, January 8th, 2020

Its been 80 million years since our our evolutionary branch diverged from mice so why do we share some fragments of DNA that are essentially unchanged? (Fred Hutch News Service Illustration / Kim Carney)

Why do some strings of genetic code remain virtually unchanged despite tens of millions of years of evolutionary divergence? A newly published study that takes advantage of the gene-editing technique known as CRISPR has found that at least some of those DNA strings are essential to keep healthy cells growing and block the growth of tumor cells.

The research, published today in Nature Genetics, is the first study finding large-scale importance of these highly conserved elements, senior author Rob Bradley of Seattles Fred Hutchinson Cancer Research Center said in a news release.

Bradley and his colleagues say unraveling the mysteries of those ultra-conserved elements could lead to new avenues for cancer treatment.

The study started out with a molecular analysis focusing on specialized snippets of DNA known as poison exons. Such snippets regulate the activity of cells by shutting off the production of particular proteins. Theyve been called kill switches for cellular functions. When they go haywire, they can cause maladies such as epilepsy. But when they work the way theyre supposed to, they can poison the production of undesirable proteins and keep cells on the right track.

Scientists have previously noticed an overlap between poison exons and ultra-conserved elements, but they puzzled over why the poison exons were so essential that theyve been relatively untouched by evolutionary pressures. In order to solve the puzzle, the Fred Hutch team made use of a CRISPR gene-editing enzyme that was modified with guide-RNA molecules to hunt down and snip out hundreds of poison exons from the DNA code in human cells.

Bradley and the studys lead author, Fred Hutch researcher James Thomas, call their technique paired guide RNAs for alternative exon removal, or pgFARM (pronounced like pig farm). Whats unique about what James did is not the approach per se, but that hes doing it in high throughput, Bradley said.

The researchers identified 465 poison exons that were highly conserved in humans, mice and rats as well as another 91 poison exons that werent so highly conserved. When they knocked out the ultra-conserved exons in cells that were grown in a lab dish, the cells died off.

As a follow-up, the team tested the role of poison exons in live mice that had lung tumors. Many of the exons were essential for normal cell growth, just as they were for the cells in the lab dish. Even more intriguingly, some of the exons had tumor-suppressing effects that were clinically relevant, the researchers reported.

Tumor-fighting poison exons tended to turn up within the genes that govern RNA splicing, a vital part of the cells protein-making machinery. Those exons may well rein in RNA-splicing factors that could otherwise promote tumor growth.

Scientists are already working on techniques to fix RNA-splicing problems that contribute to a wide variety of diseases and Thomas is hopeful that ultra-conserved poison exons could point the way to new molecular targets specific to cancer treatment.

Once you find a target, its easy to build upon the previous technology that exists for therapeutics, he said.

Update for 6:15 p.m. PT Jan. 8: Weve fine-tuned this report to describe the procedures used in the experiment more accurately. In addition to Thomas and Bradley, the authors of the Nature Genetics study, RNA Isoform Screens Uncover the Essentiality and Tumor-Suppressor Activity of Ultraconserved Poison Exons, include Jacob Polaski, Qing Feng, Emma De Neef, Emma Hoppe, Maria McSharry, Joseph Pangallo, Austin Gabel, Andrea Belleville, Jacqueline Watson, Naomi Nkinsi and Alice Berger.

See the rest here:
Scientists link mysterious snippets of DNA to cell growth and tumor suppression - GeekWire

Read More...

Sight loss research needs urgent investment – The Guardian

Wednesday, January 8th, 2020

As leading ophthalmologists and researchers we are joining the eye research charity Fight for Sight to call for urgent action on blindness in 2020 to address the research funding gap.

We know that serious sight loss doesnt discriminate it can affect anyone at any time and it is on the increase. Science can already do so much and with the advent of new gene therapies and stem cell treatments we are so close to outcomes that were not possible a decade ago. Yet so much more needs to be done to develop new universal treatments.

The main barrier is the lack of research funding. It is unacceptable that in 2020 only 1% of UK grant funding goes to eye research, even though more than 20% of people will be affected by serious sight loss in their lifetime. Blindness can have a huge impact on peoples mental health and ability to work, increasing costs on health systems and infrastructure.

In 2019 the WHO and UN general assembly both outlined that globally more investment is needed into sight loss and research. We are calling for the new government and its partners to agree a national plan on sight loss and a research agenda that will help to ensure that eye research gets the funding it badly needs. Please join us at fightforsight.org.uk and let 2020 be the year that we accelerate progress in beating blindness.

Prof Chris Hammond Frost chair of ophthalmology, Kings College London, Prof Alan Stitt Dean of innovation and impact, Queens University Belfast, Prof Alastair Denniston Consultant ophthalmologist, Birmingham University, Prof Alison Hardcastle Professor of molecular genetics, UCL Institute of Ophthalmology, Prof Lynda Erskine Chair in developmental neurobiology, Aberdeen University, Prof Jeremy Guggenheim Director of research, Cardiff University, Prof David Steel Consultant ophthalmologist, Newcastle University, Prof Chris Inglehearn Professor of molecular ophthalmology and neuroscience, Leeds University, Prof Timothy Jackson Consultant ophthalmic surgeon, Kings College London, Prof Rachael Pearson Professor of developmental neuroscience, UCL Institute of Ophthalmology, Prof Jessica Teeling Professor of Experimental Neuroimmunology, University of Southampton, Prof Colin Willoughby Professor of ophthalmology, Ulster University

Join the debate email guardian.letters@theguardian.com

Read more Guardian letters click here to visit gu.com/letters

Do you have a photo youd like to share with Guardian readers? Click here to upload it and well publish the best submissions in the letters spread of our print edition

Go here to see the original:
Sight loss research needs urgent investment - The Guardian

Read More...

Faculty and alumni appointed to state medical boards – The South End

Wednesday, January 8th, 2020

Michigan Gov. Gretchen Whitmer appointed a number of faculty members and alumni of the Wayne State University School of Medicine to several state boards overseeing medicine and medical licensing.

Appointments to the Michigan Board of Medicine, which works with the Department of Licensing and Regulatory Affairs to oversee the practice of medical doctors ascertaining minimal entry-level competency of medical doctors and requiring continuing medical education during licensure include:

Bryan Little, M.D., Class of 1998, is the specialist in chief of Orthopedic Surgery at the Detroit Medical Center. The governor also appointed Dr. Little to the Michigan Task Force on Physicians Assistants. That entity works with the Department of Licensing and Regulatory affairs to oversee the practice of physicians assistants. The terms of both appointments expire Dec. 31, 2023.

Angela Trepanier, M.S., CGC, professor of Molecular Medicine and Genetics and director of the Genetic Counseling Masters Program at the School of Medicine. She will represent genetic counselors during her term, which expires Dec. 31, 2023.

Donald Tynes, M.D., Class of 1995, clinical assistant professor for the School of Medicine and chief medical officer of the Benton Harbor Health Center, will serve a term through Dec. 31, 2023.

Hsin Wang, M.D., Class of 1999, was appointed to the Michigan Board of Licensed Midwifery, which works with the Department of Licensing and Regulatory Affairs to establish and implement the licensure program for the practice of midwifery in the state. Dr. Wang is an obstetrician-gynecologist with the Detroit Medical Center and the director of the Pelvic Health Program for DMC Huron Valley-Sinai Hospital. Her term runs through Dec. 31, 2023.

Melissa Mafiah, M.D., Class of 2014, was appointed to the Michigan Board of Occupational Therapists for a term that expires Dec. 31, 2023. Dr. Mafiah is a physical medicine and rehabilitation physician at W.H. Beaumont Hospital. The board works with the Department of Licensing and Regulatory Affairs to promulgate rules for licensing occupational therapists and ascertaining minimal entry level competency of occupational therapists and occupational therapy assistants.

Michael Dunn, M.D., chief of Medicine at the Henry Ford West Bloomfield Hospital and the senior staff physician for the hospitals Pulmonary and Critical Care Medicine Division, is an assistant clinical professor of Medicine for the School of Medicine. He was appointed to the Michigan Board of Respiratory Care, which oversees the licensure requirements and standards for respiratory therapists. His appointment runs through Dec. 31, 2023.

See the article here:
Faculty and alumni appointed to state medical boards - The South End

Read More...

Science Education and the Growth Mindset – Discovery Institute

Wednesday, January 8th, 2020

Lately, Ive been very interested in learning more about teaching and learning. Ive been involved in coaching public speaking and debate for nearly a decade, and taught ESL classes off and on, and have recently come to realize that I am an educator. I had a professor in college who told us that if we were going to read one book on a subject, we might as well read tenwed learn a lot more and if we just kept going, before we knew it all ten would be finished. Well, often I dont do that, but recently Ive been raiding the Education section at several branches of the local library systemlearning about teaching reading, differentiated learning for gifted students, controversies over giving homework, and much more.

One gem I came across was Mary Cay Riccis Mindsets in the Classroom. And it clicked with my work at Discovery.

In learning about what Ricci and others call the growth mindset, I was reminded that the way to teach critical thinking in science is to have students engage with the content like scientists.

Growth mindset is an idea popularized by Stanford psychology professor Carol Dweck. She contrasts the idea of a growth mindset that we can become smarter as we work hard and our brains make new connections to the notion of a fixed mindset that we have whatever talents we were born with, or that our growth is limited. Here is a helpful video from Dweck on growth mindset, speaking for Khan Academy.

Mary Cay Riccis book takes Dwecks concept and gives teachers concrete nuts and bolts for how to teach growth mindset in the classroom.

I found her section on critical thinking striking. She notes:

Another important factor to consider about critical thinking is that it is not a simple skill (Willingham, 2008). According to Willingham (2008), critical thinking is a process that must be infused with content; it is not something that you can just check off a list once it is mastered. Why? Well, one reason is that the content being focused on and the complexity of thinking critically becomes more sophisticated over time it is always evolving. The practice component applied to the content knowledge is essential to develop learners who can apply critical thinking when they need to. Hand in hand with practice is persistence and effort, probably the two most important attributes of having a growth mindset!

If you embrace Willinghams argument that critical thinking is not a bunch of isolated skills, then you too (like me) may become annoyed by the amount of resources on the market that advertise ways to build critical thinking skills. Due in part to the way critical thinking is framed in these resources, the concept of accepting critical thinking as a process embedded in content rather than a set of skills can require a major shift in thinking.

As an aside, note her use of the word evolution to signify things becoming more complex over time! Thats not how evolutionists use the term. But never mind that. Ricci sees critical thinking as an essential component of the growth mindset it is key to practicing new learning.

When applied to the subject of science, critical thinking as defined here becomes synonymous with scientific inquiry. Critical thinking is a process that must be infused with content.the content being focused on and the complexity of thinking critically becomes more sophisticated over time And it is true that one cannot teach critical thinking skills in isolation. There must be a content area to analyze, and the critical thinking skills for one content area are not the same as critical thinking skills for another content area. In science, critical thinking is scientific inquiry observing, coming up with hypotheses, experimenting, recording data, drawing conclusions, etc.

One of the worlds foremost science publications, the journal Nature, has noted: [S]tudents gain a much deeper understanding of science when they actively grapple with questions than when they passively listen to answers.

Also in Nature, Jay Labov, senior education advisor from the U.S. National Academy of Sciences, commented that he sees active engagement as learning content not as something you memorize and regurgitate, but as raw material for making connections, drawing inferences, creating new information learning how to learn.

Teaching evolution well means educating in relevant aspects of scientific inquiry critical thinking too. This means, in short, exposing students to current scientific inquiries in the field the relevant, recent research.

This is from Denis Noble, Professor Emeritus and co-Director of Cardiovascular Physiology at Oxford University, and Fellow of the Royal Society, writing in the journal Experimental Physiology. He describes scientists as they learn and change their views in response to evidence.

The Modern Synthesis (NeoDarwinism) is a mid20th century genecentric view of evolution, based on random mutations accumulating to produce gradual change through natural selection. Any role of physiological function in influencing genetic inheritance was excluded. The organism became a mere carrier of the real objects of selection, its genes. We now know that genetic change is far from random and often not gradual. Molecular genetics and genome sequencing have deconstructed this unnecessarily restrictive view of evolution in a way that reintroduces physiological function and interactions with the environment as factors influencing the speed and nature of inherited change. Acquired characteristics can be inherited, and in a few but growing number of cases that inheritance has now been shown to be robust for many generations. The 21st century can look forward to a new synthesis that will reintegrate physiology with evolutionary biology. [Emphasis added.]

As I said earlier, the way to teach critical thinking in science is to have students engage with the content like scientists. What could be better than exposing them to current scientific debates and asking them to examine the evidence for themselves?

What would this kind of activity foster? I can easily see it planting questions in students minds that may blossom into full-fledged scientific inquiries. The leap is not great between enjoying science in high school and trying out science classes as a freshman or sophomore in college, and onward to graduating with a STEM degree and beginning a graduate program or ones first job in industry. For fostering future scientists, physicians, and engineers, inspiration and a growth mindset are the key.

Photo credit:Chetan MenariaonUnsplash.

View original post here:
Science Education and the Growth Mindset - Discovery Institute

Read More...

Page 24«..1020..23242526..30..»


2025 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick